Faculty, Staff and Student Publications
Publication Date
6-13-2023
Journal
Blood Advances
DOI
10.1182/bloodadvances.2022009469
PMID
36661331
PMCID
PMC10248088
PubMedCentral® Posted Date
6-13-2023
PubMedCentral® Full Text Version
Post-print
Keywords
Humans, Cost-Benefit Analysis, Lymphoma, Follicular, Risk Adjustment, Rituximab, Antibodies, Monoclonal, Murine-Derived
Published Open-Access
yes
Recommended Citation
Gribben, John; Palomba, M Lia; Patel, Anik R; et al., "Need for Risk Adjustment in Comparative Effectiveness and Cost-Effectiveness Studies in R/R Follicular Lymphoma" (2023). Faculty, Staff and Student Publications. 4888.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/4888
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons